Issn Print: 0923-7534
Publication Date: 2017/09/01
Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer
A.-S. Hamy; J.-Y. Pierga; A. Sabaila; E. Laas; H. Bonsang-Kitzis; C. Laurent; A. Vincent-Salomon; P. Cottu; F. Lerebours; R. Rouzier; M. Lae; F. Reyal
Author Information: Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.